This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arizona State University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations in Gene Editing: The Contributions of Jennifer Chapman
Introduction
Jennifer Chapman is an accomplished inventor based in Phoenix, AZ. She has made significant strides in the field of gene editing, particularly through her innovative work on CRISPR technology. Her research focuses on enhancing the efficiency of gene editing methods, which has the potential to revolutionize therapeutic applications.
Latest Patents
Jennifer Chapman holds a patent for a "Universal platform to enhance CRISPR-based gene editing for in vivo therapies." This patent encompasses methods and synthetic regulatory systems aimed at improving nuclease-mediated homology-directed repair (HDR). The methods introduced in her patent involve the use of a synthetic regulatory system that includes Cas nuclease and guide RNAs (gRNAs) of varying lengths. These gRNAs are designed to target distinct nucleotide sequences, facilitating simultaneous transcriptional repression or activation alongside genome editing through double-stranded breaks. The use of a donor nucleic acid molecule as a template for repair is also a key aspect of her invention.
Career Highlights
Jennifer Chapman is affiliated with Arizona State University, where she continues to advance her research in gene editing. Her work has garnered attention for its innovative approach to improving HDR-based gene editing techniques. With a focus on both in vivo and in vitro applications, her contributions are paving the way for more effective gene therapies.
Collaborations
Jennifer has collaborated with notable researchers in her field, including Samira Kiani and Mo Reza Ebrahimkhani. These collaborations have further enriched her research and expanded the impact of her innovations in gene editing.
Conclusion
Jennifer Chapman is a pioneering inventor whose work in CRISPR-based gene editing is making significant contributions to the field of biotechnology. Her innovative approaches and collaborations are setting the stage for future advancements in gene therapy.